MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on May 23, 2006; DOI: 10.1124/mol.106.023044


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.023044v1
70/2/755    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moroni, M.
Right arrow Articles by Bermudez, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moroni, M.
Right arrow Articles by Bermudez, I.


Received for publication January 30, 2006.
Revised May 19, 2006.
Accepted for publication May 22, 2006.

{alpha}4{beta}2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry and sensitivity to chronic exposure to nicotine

Mirko Moroni 1, Ruud Zwart 2, Emanuele Sher 2, Bruce K Cassels 3, Isabel Bermudez 1*

1 Oxford Brookes University 2 Eli Lilly 3 University of Chile

* Address correspondence to: E-mail: p0054922{at}brookes.ac.uk

Abstract

{alpha}4 and {beta}2 nicotinic acetylcholine receptor (nAChR) subunits expressed heterologously assemble into high (HS) and low (LS) ACh sensitivity receptors whose relative proportions depend on the {alpha}4 to {beta}2 ratio. In this study, injection of oocytes with 1:10 {alpha}4:{beta}2 subunit cDNA ratios favored expression of HS {alpha}4{beta}2 nAChRs as evidenced by monophasic ACh concentration-response curves, whilst injections with 10:1 cDNA ratios favored expression of LS {alpha}4[beta]2 receptors. The stoichiometry was inferred from the shifts in the ACh EC50 values caused by L to T mutations at position 9' of the second transmembrane domain of {alpha}4 and {beta}2. The 1:10 injection ratio produced the ({alpha}4)2({beta}2)3 stoichiometry, whilst 10:1 injections produced the ({alpha}4)3({beta}2)2 stoichiometry. The agonists epibatidine, A-85380, TC-2559, cytisine and 3-Br-cytisine and the antagonists dihydro-{beta}-erythroidine (DH{beta}E) and d-tubocurarine were more potent at HS receptors. TC-2559 was more efficacious than ACh at HS receptors but was a partial agonist at LS receptors. Epibatidine was more efficacious than ACh at LS receptors and a partial agonist at HS receptors. Cytisine and 5-halogenated cytisines had moderate efficacy at LS receptors but had almost no efficacy at HS receptors. By exploiting the differential effects of ACh, TC-2559 and 5-I-cytisine we evaluated the effects of chronic exposure to nicotine on HS and LS receptors expressed in Xenopus oocytes after cDNA injections or microtransplantation of {alpha}4{beta}2 receptors assembled in HEK293 cells. We conclude that nicotine upregulates HS {alpha}4{beta}2 receptors, likely by influencing the assembly of receptors, rather than by altering the functional state of LS {alpha}4{beta}2 nAChRs.


Key words: Nicotinic cholinergic, Ion channel regulation, Func. analysis receptor/ion channel mutants


This article has been cited by other articles:


Home page
J. Neurosci.Home page
S. M. Kassam, P. M. Herman, N. M. Goodfellow, N. C. Alves, and E. K. Lambe
Developmental Excitation of Corticothalamic Neurons by Nicotinic Acetylcholine Receptors
J. Neurosci., August 27, 2008; 28(35): 8756 - 8764.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Moroni, R. Vijayan, A. Carbone, R. Zwart, P. C. Biggin, and I. Bermudez
Non-Agonist-Binding Subunit Interfaces Confer Distinct Functional Signatures to the Alternate Stoichiometries of the {alpha}4{beta}2 Nicotinic Receptor: An {alpha}4-{alpha}4 Interface Is Required for Zn2+ Potentiation
J. Neurosci., July 2, 2008; 28(27): 6884 - 6894.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Kuryatov, J. Onksen, and J. Lindstrom
Roles of Accessory Subunits in {alpha}4{beta}2* Nicotinic Receptors
Mol. Pharmacol., July 1, 2008; 74(1): 132 - 143.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Gotti, M. Moretti, N. M. Meinerz, F. Clementi, A. Gaimarri, A. C. Collins, and M. J. Marks
Partial Deletion of the Nicotinic Cholinergic Receptor {alpha}4 or {beta}2 Subunit Genes Changes the Acetylcholine Sensitivity of Receptor-Mediated 86Rb+ Efflux in Cortex and Thalamus and Alters Relative Expression of {alpha}4 and {beta}2 Subunits
Mol. Pharmacol., June 1, 2008; 73(6): 1796 - 1807.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Zwart, A. L. Carbone, M. Moroni, I. Bermudez, A. J. Mogg, E. A. Folly, L. M. Broad, A. C. Williams, D. Zhang, C. Ding, et al.
Sazetidine-A Is a Potent and Selective Agonist at Native and Recombinant {alpha}4{beta}2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., June 1, 2008; 73(6): 1838 - 1843.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X. M. Shao, W. Tan, J. Xiu, N. Puskar, C. Fonck, H. A. Lester, and J. L. Feldman
{alpha}4* Nicotinic Receptors in preBotzinger Complex Mediate Cholinergic/Nicotinic Modulation of Respiratory Rhythm
J. Neurosci., January 9, 2008; 28(2): 519 - 528.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Tapia, A. Kuryatov, and J. Lindstrom
Ca2+ Permeability of the ({alpha}4)3(beta2)2 Stoichiometry Greatly Exceeds That of ({alpha}4)2(beta2)3 Human Acetylcholine Receptors
Mol. Pharmacol., March 1, 2007; 71(3): 769 - 776.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Kishi and J. H. Steinbach
Role of the Agonist Binding Site in Up-Regulation of Neuronal Nicotinic {alpha}4beta2 Receptors
Mol. Pharmacol., December 1, 2006; 70(6): 2037 - 2044.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics